Mutations in RAF1 are extremely rare; however, overexpression of CRAF is correlated with disease progression in a subset of human cancers, including melanoma, non-small cell lung cancer (NSCLC), and hepatocellular carcinoma [102, 138, 139]. Here, RAF1 is linked to melanoma.